Dragonforce ransomware group lists medipakpharma.com on its leak site

• Ransomware group: Dragonforce
• Country: Pakistan
• Sector: Healthcare
• Announcement date: June 29, 2026

Dragonforce claims data breach at Medipak Limited

The Dragonforce ransomware group has published an announcement on its leak site claiming to have compromised data belonging to medipakpharma.com. This claim suggests that the organization has been targeted in a cyberattack, with the threat actor asserting that they have successfully exfiltrated information from the company's systems.

Ransomware attacks often involve a tactic known as double extortion. In these scenarios, attackers do not merely encrypt a victim's files to disrupt operations; they also steal sensitive data to use as leverage. By threatening to release this information publicly or sell it to third parties, the attackers increase the pressure on the organization to meet their demands. This method aims to maximize the impact of the breach by targeting the victim's reputation and legal standing.

Details of the alleged exfiltration

According to the announcement made by the Dragonforce group, the breach involves a significant volume of information. The group claims to have stolen a dataset that is approximately 9.79 GB in size. While the specific nature of the stolen files has not been detailed, the group indicates that the exfiltrated data allegedly contains both operational and corporate information.

The listing does not provide specific details regarding the exact types of files or the specific content of the data. Furthermore, no information was provided regarding the total file count or the specific ransom demand requested by the attackers. The group has suggested that the stolen data may be released to the public or shared with various third parties.

About Medipak Limited

Medipak Limited is a pharmaceutical company based in Pakistan. The organization specializes in the manufacturing of various medical products, including infusion solutions and medical devices, as well as a range of other pharmaceutical products.

Potential impact and industry implications

The alleged leak poses significant risks to the organization's intellectual property and trade secrets. Because the entity operates within the pharmaceutical sector, the compromised data could potentially include sensitive information related to manufacturing processes or supply chain details. Such information is often critical to the competitive advantage and operational integrity of pharmaceutical firms.

The disclosure of such data can lead to various negative consequences for an organization. These include potential impacts on operational continuity and damage to the company's market reputation. Additionally, the exposure of sensitive corporate or operational information could complicate the organization's ability to meet its legal and regulatory compliance obligations.

The Dragonforce group has been active since 2023 and is reported to provide infrastructure to various affiliates. This capability means that a single successful breach can facilitate secondary attacks or lead to a wider ecosystem of threats. For organizations in highly regulated sectors like healthcare and pharmaceuticals, maintaining robust defensive postures is essential. This typically involves implementing strict access controls, continuous monitoring of network traffic, and regular security awareness training to mitigate the risk of unauthorized data exfiltration.